Intrinsic Value
Allogene Therapeutics, Inc. (ALLO)
$3.07
+0.10 (+3.37%)
| Enterprise Value | - |
|---|---|
| Net Debt | 11.97 |
| Equity Value | - |
| Shares Outstanding | 156.93 |
| Equity Value Per Share | - |
Because investors are more interested in the value of the company’s shares alone, we’ll deduct net debt from this value to arrive at a fair value of the company’s equity. Fair Value = Enterprise Value – Debt